Biologics

PUBLISHER: 360iResearch | PRODUCT CODE: 1379321

PUBLISHER: 360iResearch | PRODUCT CODE: 1379321

Immunochemicals Market by Product (Antibodies, Cytokines & Chemokines, Immunoglobulins), Source (Animal-Derived, Synthetic), Application, End-User - Global Forecast 2023-2030

PUBLISHED: October 16, 2023

PAGES: 184 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Immunochemicals Market is projected to reach USD 4.75 billion by 2030 from USD 2.73 billion in 2022, at a CAGR of 7.14% during the forecast period.

Global Immunochemicals Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 2.73 billion
Estimated Year Value [2023]	USD 2.92 billion
Forecast Year Value [2030]	USD 4.75 billion
CAGR (%)	7.14%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Immunochemicals Market.

Based on Product, market is studied across Antibodies, Cytokines & Chemokines, and Immunoglobulins. The Cytokines & Chemokines is projected to witness significant market share during forecast period.

Based on Source, market is studied across Animal-Derived and Synthetic. The Animal-Derived is projected to witness significant market share during forecast period.

Based on Application, market is studied across Autoimmune Disease, Infectious Disease, Neurology, and Oncology. The Oncology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Contract Research Organizations, Forensic Organizations, and Research & Academic Institutes. The Biotechnology & Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Immunochemicals Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Immunochemicals Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Immunochemicals Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, Active Motif Incorporated, Agilent Technologies, Inc., AMS Biotechnology (Europe) Limited., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biocare Medical, LLC, BioGenex Laboratories, Biosynth Laboratories, BMA Biomedicals, Cayman Chemical, Cell Signaling Technology, Inc., Creative Diagnostics, Danahar Corporation, Elabscience Biotechnology Inc., F. Hoffmann-La Roche Ltd, Fortis Life Sciences, GE Healthcare, Genemed Biotechnologies, Inc., GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotech, MyBioSource, Origene Technologies Inc., PerkinElmer, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Specifica Inc., and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Immunochemicals Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Immunochemicals Market?

3. What is the competitive strategic window for identifying opportunities in the Immunochemicals Market?

4. What are the latest technology trends and regulatory frameworks in the Immunochemicals Market?

5. What is the market share of the leading vendors in the Immunochemicals Market?

6. Which modes and strategic moves are suitable for entering the Immunochemicals Market?

Product Code: MRR-C002B1C99526

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunochemicals Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing drug discovery and development activities worldwide
  - 5.1.1.2. Government support for immunochemistry, genomics, and proteomics research
  - 5.1.1.3. Use of immunochemical techniques for early disease detection and diagnosis
- 5.1.2. Restraints
  - 5.1.2.1. Risk of cross-contamination and possibilities of false positives in test kits
- 5.1.3. Opportunities
  - 5.1.3.1. Rise of advanced formulations of immunochemical for research
  - 5.1.3.2. Adoption of nanotechnology to develop advanced clinical diagnostic test kits
- 5.1.4. Challenges
  - 5.1.4.1. Strict regulatory guidelines regarding the production and use of immunochemical
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunochemicals Market, by Product

6.1. Introduction
6.2. Antibodies
6.3. Cytokines & Chemokines
6.4. Immunoglobulins

7. Immunochemicals Market, by Source

7.1. Introduction
7.2. Animal-Derived
7.3. Synthetic

8. Immunochemicals Market, by Application

8.1. Introduction
8.2. Autoimmune Disease
8.3. Infectious Disease
8.4. Neurology
8.5. Oncology

9. Immunochemicals Market, by End-User

9.1. Introduction
9.2. Biotechnology & Pharmaceutical Companies
9.3. Clinical Laboratories
9.4. Contract Research Organizations
9.5. Forensic Organizations
9.6. Research & Academic Institutes

10. Americas Immunochemicals Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Immunochemicals Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Immunochemicals Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Abbiotec, Inc.
- 14.1.2. Abcam PLC
- 14.1.3. Active Motif Incorporated
- 14.1.4. Agilent Technologies, Inc.
- 14.1.5. AMS Biotechnology (Europe) Limited.
- 14.1.6. Becton, Dickinson and Company
- 14.1.7. Bio-Rad Laboratories, Inc.
- 14.1.8. Bio-Techne Corporation
- 14.1.9. Biocare Medical, LLC
- 14.1.10. BioGenex Laboratories
- 14.1.11. Biosynth Laboratories
- 14.1.12. BMA Biomedicals
- 14.1.13. Cayman Chemical
- 14.1.14. Cell Signaling Technology, Inc.
- 14.1.15. Creative Diagnostics
- 14.1.16. Danahar Corporation
- 14.1.17. Elabscience Biotechnology Inc.
- 14.1.18. F. Hoffmann-La Roche Ltd
- 14.1.19. Fortis Life Sciences
- 14.1.20. GE Healthcare
- 14.1.21. Genemed Biotechnologies, Inc.
- 14.1.22. GenScript Biotech Corporation
- 14.1.23. Merck KGaA
- 14.1.24. Miltenyi Biotech
- 14.1.25. MyBioSource
- 14.1.26. Origene Technologies Inc.
- 14.1.27. PerkinElmer, Inc.
- 14.1.28. Rockland Immunochemicals, Inc.
- 14.1.29. Santa Cruz Biotechnology
- 14.1.30. Specifica Inc.
- 14.1.31. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing